Osterweis Capital Management Inc Nektar Therapeutics Transaction History

Osterweis Capital Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $3.98 Million - $6.76 Million	-367,113 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $81,752 - $117,844	-6,255 Reduced 1.68%	367,113 $6.59 Million
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $356,187 - $439,844	-21,561 Reduced 5.46%	373,368 $6.41 Million
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $489,761 - $752,979	-29,575 Reduced 6.97%	394,929 $7.9 Million
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $827,925 - $999,075	-52,500 Reduced 11.01%	424,504 $7.22 Million
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $275,095 - $411,067	-16,582 Reduced 3.36%	477,004 $7.91 Million
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $3.08 Million - $4.29 Million	-182,910 Reduced 27.04%	493,586 $11.4 Million
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $5.92 Million - $11.4 Million	409,366 Added 153.25%	676,496 $12.1 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $1.7 Million - $2.48 Million	-107,225 Reduced 28.64%	267,130 $5.77 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $2.61 Million - $5.59 Million	154,065 Added 69.94%	374,355 $6.82 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $6.83 Million - $8 Million	220,290 New	220,290 $7.84 Million

153

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $165M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.